ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.90
0.66%
US Tech 100
19,350.80
0.45%
S&P 500
5,482.87
0.09%
US Dollar vs CAD
1.36956
-0.03%
Bitcoin
61,436.37
-0.28%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enliven Therapeutics Inc (ELVN)

  7. Enliven Therapeutics Inc (ELVN) News

ELVN

Enliven Therapeutics (ELVN)

Enliven Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELVN
DateTimeSourceHeadlineSymbolCompany
06/18/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELVNEnliven Therapeutics Inc
06/10/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/31/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/30/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/30/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/29/20243:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/29/20243:06PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
05/29/20243:05PMGlobeNewswire Inc.Enliven Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:ELVNEnliven Therapeutics Inc
05/28/20244:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/28/20244:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/16/20246:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/14/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELVNEnliven Therapeutics Inc
05/14/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELVNEnliven Therapeutics Inc
05/14/20243:05PMGlobeNewswire Inc.Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business UpdateNASDAQ:ELVNEnliven Therapeutics Inc
05/13/20246:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/08/20247:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
05/07/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
04/11/20246:55AMGlobeNewswire Inc.Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid LeukemiaNASDAQ:ELVNEnliven Therapeutics Inc
04/09/20243:05PMGlobeNewswire Inc.Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of DirectorsNASDAQ:ELVNEnliven Therapeutics Inc
03/28/20243:05PMGlobeNewswire Inc.Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024NASDAQ:ELVNEnliven Therapeutics Inc
03/19/20247:30AMGlobeNewswire Inc.Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline UpdatesNASDAQ:ELVNEnliven Therapeutics Inc
03/14/20243:05PMGlobeNewswire Inc.Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business UpdateNASDAQ:ELVNEnliven Therapeutics Inc
03/08/20246:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
03/06/20244:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
03/04/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
02/29/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
02/27/20243:05PMGlobeNewswire Inc.Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:ELVNEnliven Therapeutics Inc
02/27/20243:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
02/20/20246:35PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
02/20/20246:27PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ELVN

Your Recent History

AQSE
RCH.GB
Reach
BIT
NSCIT000A250
Reconstruction Credit In...
NASDAQ
WTFCM
Wintrust Financial
BIT
I07336
INTESA SANPAOLO
BIT
I09568
IT0005561847 20250915 12...
BIT
UB3JTQ
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved